Article Dump
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Drug Abuse > Hydrocodone Addiction

Tags

  • combination
  • challenges
  • others
  • companies involved
  • companies involved
  • companies involved

  • Links

  • Logo Design: The Priceless Asset For Your Company's Identity
  • Is Phoenix Real Estate Headed for Boom or Bust
  • Fish Out Of Water
  • Article Dump - Hydrocodone Addiction

    Hydrocodone is an opioid or a narcotic that can elicit a euphoric, calm state that is very similar to the effects that morphine or her
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    oin gives. It is thus very beneficial to those who suffer from chronic and long lasting pain. However, despite these obvious benefits,
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    evidence points towards the direction of chronic addiction. Pure hydrocodone belongs to the Schedule II drug category, which simply me
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    ans that it is controlled and use of the drug is highly restricted. However, there are only a few prescription drugs that are made of
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ure hydrocodone. Most of them available in the market contain only small amounts of hydrocodone mixed with non-narcotic ingredients, s
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ch as in Vicodin and Lortab. When so, they are classified to be under the Schedule III categories with expectedly fewer restrictions o
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    n distribution and use.

    There are more than 200 pain killers marketed today that contain hydrocodone - Vicodin, Hycodan, Norco, Lorce
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    , Lortab, Hydroco, Vicoprofen and Xodol, among many others. They can vary from tablet, capsule to syrup in form. Common side effects o
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    f taking drugs with hydrocodone include light-headedness, nausea, drowsiness, vomiting, constipation and euphoria. Other less common s
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    de effects include mood changes, blood disorders, anxiety, lethargy, repressed or irregular respiration, rashes and difficulty urinati
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    g. Taking alcohol with hydrocodone can intensify drowsiness to a greater extent, and may even lead to toxic overdose.

    Depending on th
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    e individual, many experts believe that addiction can occur from two to four weeks upon taking the drug at higher doses. It is habit-f
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    rming, and can consequently lead to physiological addiction with continued use.

    Structurally, hydrocodone is related to codeine and i
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ts strength is more or less equal to that of morphine in terms of producing opiate-like euphoric effects. For more detailed informatio
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    on specific hydrocodone-based addictions, their effects and potential risks, you can visit http://www.mypainkilleraddictions.com.

    Hy
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    rocodone users who decrease the intake dosage or suddenly stop taking the drug will experience withdrawal symptoms as soon as six to t
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    en hours after the last dose. The symptoms are often not life threatening, but the intensity of it depends on the degree of hydrocodon
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    addiction. In most cases, the withdrawal symptoms grow stronger within 48 to 72 hours, and then gradually decrease within a week or t
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    wo. The duration by which a user feels the withdrawal symptoms vary from one person to another. Common withdrawal symptoms include int
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    nse craving for the drug, diarrhea, irritability, runny nose, dilated pupils, extreme sweating, fever, chills, insomnia and depression


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.articledump.org.ua/article/242903/articledump-Hydrocodone-Addiction.html">Hydrocodone Addiction</a>

    BB link (for phorums):
    [url=http://www.articledump.org.ua/article/242903/articledump-Hydrocodone-Addiction.html]Hydrocodone Addiction[/url]

    Related Articles:

    Five Tips For Selling Digital Goods On Ebay

    Making a Claim for Medical Negligence Compensation in the UK

    The Benefits of Using Tanning Creams

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com